Vitasora Health (ASX:VHL) Days Payable: 0.00 (As of Dec. 2025)


What is Vitasora Health Days Payable?

Vitasora Health ASX:VHL Days Payable is 0.00 as of Dec. 2025. The stock has 6 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Vitasora Health ranks better than 99.34% on this metric.

Vitasora Health's average Accounts Payable for the six months ended in Dec. 2025 was A$2.62 Mil. Vitasora Health's Cost of Goods Sold for the six months ended in Dec. 2025 was A$0.00 Mil.

The historical rank and industry rank for Vitasora Health's Days Payable or its related term are showing as below:

ASX:VHL' s Days Payable Range Over the Past 10 Years
Min: 281.77   Med: 3373.72   Max: 28893.74
Current: 28893.74

During the past 13 years, Vitasora Health's highest Days Payable was 28893.74. The lowest was 281.77. And the median was 3373.72.

ASX:VHL's Days Payable is ranked better than
99.34% of 607 companies
in the Healthcare Providers & Services industry
Industry Median: 58 vs ASX:VHL: 28893.74

Vitasora Health's Days Payable declined from Dec. 2024 (327,405.00) to Dec. 2025 (0.00). It may suggest that Vitasora Health accelerated paying its suppliers.


Vitasora Health Days Payable Historical Data

* Premium members only.

The historical data trend for Vitasora Health's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitasora Health Days Payable Chart

Vitasora Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 281.77 1,125.88 5,621.55 0.00 28,841.08

Vitasora Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89,310.94 0.00 327,405.00 14,017.89 0.00

ASX:VHL vs VEEV, BTSG, TEM: Days Payable Comparison

For the Health Information Services subindustry, Vitasora Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitasora Health Days Payable vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vitasora Health's Days Payable distribution charts can be found below:

* The bar in red indicates where Vitasora Health's Days Payable falls into.



Vitasora Health Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Vitasora Health's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as

Days Payable (A: Jun. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2024 ) + Accounts Payable (A: Jun. 2025 )) / count ) / Cost of Goods Sold (A: Jun. 2025 )*Days in Period
=( (1.937 + 2.804) / 2 ) / 0.03*365
=2.3705 / 0.03*365
=28,841.08

Vitasora Health's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (2.804 + 2.432) / 2 ) / 0*365 / 2
=2.618 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Vitasora Health (ASX:VHL) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vitasora Health and its competitors. Over the past decade, Vitasora Health's Days Payable has ranged from 281.77 to 28,893.74. According to the industry distribution chart, Vitasora Health ranks #4 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 0.7%.
Is Vitasora Health's Days Payable too high?
Vitasora Health's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 281.77 to a high of 28,893.74. Based on the distribution chart, Vitasora Health ranks #4 out of 607 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Vitasora Health's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitasora Health ranks #4 out of 607 companies for Days Payable. This places Vitasora Health in the top 1% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.00. Historically, Vitasora Health's own Days Payable has ranged from 281.77 to 28,893.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vitasora Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitasora Health's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitasora Health stock overvalued right now?
Vitasora Health (ASX:VHL) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vitasora Health (ASX:VHL), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitasora Health Business Description

Other Exchanges VHLUF:USA
Address 432 Street Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.